Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
Stanford University
Alpha-9 Oncology USA Inc.
Fred Hutchinson Cancer Center
Mayo Clinic
Mayo Clinic
National Institutes of Health Clinical Center (CC)
H. Lee Moffitt Cancer Center and Research Institute
Massachusetts General Hospital
Ankyra Therapeutics, Inc
M.D. Anderson Cancer Center
MonTa Biosciences ApS
ViroMissile, Inc.
Pfizer
Pfizer
H. Lee Moffitt Cancer Center and Research Institute
Pfizer
Tizona Therapeutics, Inc
Aulos Bioscience, Inc.
Replimune Inc.
Essen Biotech
Essen Biotech
OHSU Knight Cancer Institute
University of Oklahoma
Werewolf Therapeutics, Inc.
MacroGenics
ModernaTX, Inc.
Adaptimmune
Second Life Therapeutics
NRG Oncology
Onchilles Pharma Inc
UNICANCER
Ocellaris Pharma, Inc.
Pierre Fabre Medicament
Mayo Clinic
OncoNano Medicine, Inc.
City of Hope Medical Center